this post was submitted on 11 Feb 2026
1 points (100.0% liked)

China News

90 readers
8 users here now

A community for china news

founded 3 months ago
MODERATORS
 

China’s state-backed investors are stepping up funding for artificial intelligence-driven drug developers as Beijing pushes for technological self-reliance, with at least one company already advancing an AI-designed therapy into late-stage clinical trials. Hangzhou-based METiS TechBio, founded in 2020, raised 400 million yuan in Series D financing in August last year, led by the Beijing Medical and Health Industry Investment Fund and the Daxing Industrial Investment Fund – both government-linked...


From China - South China Morning Post via This RSS Feed.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here